Magnetic resonance imaging in the diagnosis of benign and malignant pelvic tumors;Magnetresonanztomographie benigner und maligner tumoren des weiblichen beckens

RoFo Fortschritte auf dem Gebiet der Rontgenstrahlen und der Bildgebenden Verfahren

Volumn 176, Issue 6, 2004, Pages 817-828

  Hauth, Elke A M ^a   Stattaus, J ^a   Debatin, J F ^a   Ruehm, S G ^a  

^a UNIVERSITY HOSPITAL ESSEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BENIGN TUMOR; CANCER STAGING; CONTRAST ENHANCEMENT; DIAGNOSTIC VALUE; ENDOMETRIUM CARCINOMA; FEMALE; FEMALE GENITAL TRACT TUMOR; HUMAN; MALIGNANT NEOPLASTIC DISEASE; NUCLEAR MAGNETIC RESONANCE IMAGING; OVARY TUMOR; PELVIS TUMOR; PRIORITY JOURNAL; REVIEW; SENSITIVITY AND SPECIFICITY; SYSTEMATIC REVIEW; TERATOMA; UTERINE CERVIX CANCER; UTERUS MYOMA;

EID: 3042679809     PISSN: 14389029     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2004-813157     Document Type: Review

References (60)

1. Higgins CB, Hricak H, Helms CA. Magnetic Resonance Imaging of the body. Third Edition. New York: Lippincott-Raven Press, 1997: 761-814
2. Jain KA, Jeffrey RB Jr. Evaluation of pelvic masses with magnetic resonance imaging and ultrasonography. J Ultrasound Med 1994; 13 (11): 845-453
3. Rieber A, Nüssle K, Stohr I et al. Preoperative diagnosis of ovarian tumors with MR imaging: Comparison with transvaginale sonography, positron emission tomography, and histologic findings. Am J Roentgenol 2001; 177 (1): 123-129
4. Siegelmann ES, Outwater EK. Tissue characterization in the female pelvis by means of MR imaging. Radiology 1999; 212: 5-18
5. Kerr-Wilson RM, Shingleton HM, Orr JN. The use of US and CT scanning in the management of the gynecologic cancer patient. Gynecol Oncol 1984; 18: 54-61
6. Hricak H, Carrington BM. MRI of the pelvis. A text atlas. London: Martin Dunitz, 1990: 93-248
7. Schellock F, Curtis JS. MR imaging and biomedical implants, materials, and devices: An updated review. Radiology 1999; 180: 541-550
8. Hauth EAM, Antoch G, Debatin JF et al. Radiologische Diagnostik in der Schwangerschaft. Der Onkologe 2002; 8: 1294-1301
9. Boss EA, Barnetsz JO, Massuger LFAG et al. The role of MR imaging in invasive cercival carcinoma. European Radiology 2000; 10: 256-370
10. Forstner R, Graf A. Bildgebende Diagnostik im Staging gynäkologischer Karzinome. Radiologe 1999; 39: 610-618
11. Liu PF, Krestin GP, Huch RA et al. MRI of the uterus, uterine cervix and vagina: diagnostic performance of dynamic contrast-enhanced fast multiplanar gradient-echo imaging in comparison with fast spin-echo T2-weighted pulse imaging. European Radiology 1998; 8: 1433-1440
12. Smith RC, Reinhold C, McCauley TR et al. Multicoil high-resolution fast spin-echo MR imaging of the female pelvis. Radiology 1992; 184: 671-675
13. Kubik-Huch RA. Female pelvis. European Radiology 1999; 9: 1715-1721
14. Higgins CB, Hricak H, Helms CA. Magnetic Resonance Imaging of the body. Third Edition. New York: Lippincott-Raven Press, 1997: 816-844
15. Haynor D, Mack L, Soules MR et al. Changing appearance of the normal uterus during the menstrual cycle: MR studies. Radiology 1986; 161: 459-462
16. Outwater EK, Mitchell DG. Normal ovaries and functional cysts: MR appearance. Radiology 1996; 198: 397-402
17. Togashi K, Nakai A, Sugimura K. Anatomy and physiology of the female pelvis: MR imaging revisited. J Magn Reson Imaging 2001; 13: 842-849
18. Hamm B, Kubik-Huch RA, Fleige B. MR imaging and CT of the female pelvis: radiologic-pathologic correlation. Eur Radiol 1999; 9: 3-15
19. Gross BH, Silver TM, Jaffe MH. Sonographic features of uterine leiomyomas. JUIM 1983; 2: 401-406
20. Dueholm M, Lundorf E, Hansen ES et al. Accuracy of magnetic resonance imaging and transvaginal ultrasonography in the diagnosis, mapping and measurement of uterine myomas. Am J Obstet Gynecol 2002; 186 (3): 409-415
21. Hricak H, Tscholakoff D, Heinrichs L et al. Uterine leiomyoma correlation by magnetic resonance imaging: clinical symptoms and histopathology. Radiology 1986; 158: 385-391
22. Kröncke TJ, Gauruder-Burmeister A, Hamm B. Transarterielle Embolisation von Uterusmyomen - Eine neue Therapieoption bei symptomatischem Uterus myomatosus. Fortschr Röntgenstr 2002; 174: 1227-1235
23. Hamm B, Krestin GP, Laniado M et al. MRT von Abdomen und Becken. Kapitel 11: Uterus und Vagina. Stuttgart: Thieme, 1999: 221-263
24. Mark AS, Hricak H, Heinrichs LW et al. Adenomyosis and leiomyoma: differential diagnosis by means of magnetic resonance imaging. Radiology 1987; 163: 527-529
25. Togashi K, Nishimura K, Itoh K et al. Adenomyosis: Diagnosis with MR imaging. Radiology 1988; 166: 111-114
26. Grasel RP, Outwater EK, Siegelman ES et al. Endometrial polyps: MR imaging features and distinction from endometrial carcinoma. Radiology 2000; 214: 47-52
27. American Cancer Society. Cancer facts and figures - 1996. Atlanta: American cancer Society, 1996
28. Savci G, Ozyaman T, Tutar M et al. Assessment of depth of myometrial invasion by endometrial carcinoma: comparison of T2-weighted SE and contrast-enhanced dynamic GRE MR imaging. European Radiology 1998; 8: 218-223
29. Hardesty LA, Sumkin JH, Nath ME et al. Use of preoperative MR imaging in the management of endometrial carcinoma: cost analysis. Radiology 2000; 215: 45-49
30. Frei KA, Kinkel K. Staging endometrial cancer: Role of magnetic resonance imaging. J Magn Reson Imaging 2001; 13: 850-855
31. Kinkel K, Kaji Y, Yu KK et al. Radiologic staging in patients with endometrial cancer: a meta-analysis. Radiology 1999; 212: 711-718
32. Hamm B, Pöllinger A. Radiologische Schnittbilddiagnostik beim Endometriumkarzinom. Zentralbl Gynäkol 2002; 124: 27-31
33. Arbeitsgemeinschaft für Gynäkologische Onkologie (AGO). Leitlinien der Deutschen Gesellschaft für Gynäkologie und Geburtshilfe (DGGG) 1998: Diagnostische und therapeutische Standards beim Endometriumkarzinom (ICD 182). AWMF-Leitlinienregister Nr. 015/002.
34. Marincek B. Gynäkologie. In: Fuchs WA (Hrsg). Radiologie. Diagnostik durch bildgebende Verfahren. Bern: Verlag Hans Huber, 1996: 529-541
35. De Souza NM, Whittle M, Williams AD et al. Magnetic resonance imaging of the primary site in stage I cervical carcinoma: A comparison of endovaginal coil with external phased array coil techniques at 0,5 T. J Magn Reson Imaging 2000; 12: 1020-1026
36. Yamashita Y, Baba T, Baba Y et al. Dynamic contrast-enhanced MR imaging of uterine cervical cancer: Pharmakokinetic analysis with histopathgologic correlation and its importance in predicting the outcome of radiation therapy. Radiology 2000; 215: 803-809
37. Scheidler J, Heuck A, Wencke K et al. Parametrane Infiltration beim Zervixkarzinom: Diagnostische Wertigkeit von kontrastverstärkten fettsupprimierten T1-gewichteten Se-Sequenzen bei 1,5 Tesla. Fortschr Röntgenstr 1997; 166: 312-316
38. Gusberg SB, Runowicz CD. Gynecologic cancers. In: Hollen AI, Fink DJ, Murphy GB (Hrsg). Clinical oncology. American Cancer Society, 1991: 481-497
39. Scheidler J, Heuck AF, Steinborm M et al. Parametrial invasion in cervical carcinoma. Evaluation of detection at MR imaging with fat supression. Radiology 1998; 206: 125-129
40. Togashi K, Morikawa K, Kataoka M et al. Cervical cancer. JMRI 1998; 8: 391-397
41. UICC. TNM-Klassifikation maligner Tumoren. Berlin: Springer, 2003
42. Sahdev A, Sohaib SA, Jacobs I et al. MR Imaging of uterine sarcomas. AJR Am J Roentgenol 2001; 177: 1307-1311
43. Jain KA, Freidman D, Pettinger TW et al. Adnexal masses: comparison of specificity of endovaginal US and pelvic MR imaging. Radiology 1993; 186: 697-704
44. Yamashita Y, Torashima M, Hatanaka Y et al. Adnexal masses. Accuracy of characterization with transvaginal US and precontrast and postcontast MR imaging. Radiology 1995; 194: 557-565
45. Fenchel S, Grab D, Nüssle K et al. Asymptomatic adnexal masses: correlation of FDG PET and histopathologic findings. Radiology 2002; 223: 780-788
46. Kurtz AB, Tsimikas JV, Tempany CM et al. Diagnosis and staging of ovarian cancer: comparative values of doppler and conventinal US, CT and MR imaging correlated with surgery and histopathologic analysis-report of the radiology diagnostic oncology group. Radiology 1999; 212: 19-27
47. Kawamoto S, Katsuhiko S, Matsumoto H et al. Multiple mobile spherules in mature cystic teratoma of the ovary. Am J Roentgenol 2001; 176: 1455-1457
48. Russel P. Surface epithelial-stromal tumors of the ovary. In: Kurman RJ (Hrsg). Blaustein's pathology of the female genital tract. New York: Springer-Verlag, 1994: 708-775
49. Hussain SM, Outwater EK, Siegelman ES. MR imaging features of pelvic mucinous carcinomas. European Radiology 2000; 10: 885-891
50. Minutoli F, Blandino A, Geta M et al. Twisted ovarian fibroma with high singal intensity on T1-weighted MR image: a new sign of torsion of ovarian tumors? European Radiology 2001; 11: 1151-1154
51. Low RN, Carter WD, Saleh F et al. Ovarian cancer: comparison of findings with perfluorocarbon-enhanced MR imaging, In-111-CYT-103 immunoscintigraphy, and CT. Radiology 1995; 195: 391-400
52. Low RN, Sigeti JS. MR imaging of peritoneal disease: comparison of contrast-enhanced fast multiplanare spoiled gradient-recalled and spin-echo imaging. Am J Röntgenol 1994; 163: 1131-1140
53. Low RN, Barone RM, Lacey C et al. Peritoneal tumor: MR imaging with dilute oral barium and intravenous gadolinium-containing contrast agents compared with unenhanced MR imaging and CT. Radiology 1997; 204: 513-520
54. Stevens SK, Hricak H, Stern JL. Ovarian lesions: detection and charaterization with gadolinium-enhanced MR imaging at 1,5 T. Radiology 1991; 181: 481-488
55. Forstner R, Hriacak H, White S. CT and MRI of ovarian cancer. Abdominal Imaging 1995; 20: 3-8
56. Williams AD, Cousins C, Soutter WP et al. Detection of pelvic lymph node metastases in gynaecologic malignancy. Am J Roentgenol 2001; 177: 343-348
57. Yang WT, Man Lam WW, Yu MY et al. Comparison of dynamic helical CT and dynamic MR imaging in the evaluation of pelvic lymph nodes in cervical carcinoma. Am J Roentgenol 2000; 175: 759-766
58. McCauley TR, Rifkin MD, Ledet CA. Pelvic lymph node visualization with MR imaging using local administration of ultra-small superparamagentic iron oxide contrast. J Magn Reson Imaging 2002; 4: 492-397
59. Massuger LF, Vierzen PB, Engelke U et al. 1H-magnetic resonance spectroscopy: a new technique to discriminate benign from malignant ovarian tumor. Cancer 1998; 82: 1726-1730
60. Moteki T, Ishizaka H. Diffusion-weighted EPI of cystic ovarian lesions: Evaluation of cystic contents using apparent diffusion coefficients. J Magn Reson Imaging 2000; 12: 1014-1019